Concepedia

Fabrizio Micheli

FM

Statistics

Publications

55

Citations

1.6K

H-Index

24

Active since

1990

Affiliations

GlaxoSmithKline (Italy)(Current)

GlaxoSmithKline (United Kingdom)

Aptuit (Italy)

Harlow College

Novartis (Switzerland)

Fabrizio Micheli is an author at GlaxoSmithKline (Italy) specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

1990–2023

55

Publications

55

1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines:  A Series of Potent and Selective Dopamine D<sub>3</sub>Receptor Antagonists

Fabrizio Micheli, Giorgio Bonanomi, Frank E. Blaney et al. · Journal of Medicinal Chemistry · 2007 · 84 citations · Full text

, , +14

Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach

Manolo Mugnaini, Laura Iavarone, Palmina Cavallini et al. · Neuropsychopharmacology · 2012 · 83 citations · Full text

, , +12

Substituted Indole-2-carboxylates as <i>in Vivo</i> Potent Antagonists Acting as the Strychnine-Insensitive Glycine Binding Site

Romano Di Fabio, Anna Maria Capelli, Nadia Conti et al. · Journal of Medicinal Chemistry · 1997 · 81 citations · Full text

, , +17

Stereoselective synthesis of statin analogues.

Anna Bernardi, Fabrizio Micheli, Donatella Potenza et al. · Tetrahedron Letters · 1990 · 76 citations

, , +6

6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor

Fabrizio Micheli, Paolo Cavanni, Daniele Andreotti et al. · Journal of Medicinal Chemistry · 2010 · 69 citations · Full text

, , +16

1–5 of 55